FDA Inspection 1199398 — Oklahoma Blood Institute Norman Center
The FDA completed an inspection of Oklahoma Blood Institute Norman Center on February 28, 2023 in Norman, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 28, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Norman, OK (United States)